Q2 FY2026 Earnings
Financial report interval: 2025.10.01 - 2025.12.31
Overview: CERYVYN THERAPEUTICS LTD SPON ADR EACH REP 8 ORD SHS(CYVNY) the Revenue is 334.74 (-99.55%);the EBIT is -2.364 M (+94.21%);the EPS is 0.683 (+266.5%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B99.55%
----
----
EBIT
-0.00B94.21%
----
----
EPS
0.6834266.45%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf